Popular Articles

HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
The Pittsburgh Post-Gazette profiled the Girlfriends Project, a domestic violence and HIV/AIDS education program implemented by the Pittsburgh AIDS Task Force that targets at-risk black women in three Allegheny County, Pa., cities. Blacks "comprise just 7 percent of the total population in southwestern Pennsylvania but 41 percent of those living with HIV/AIDS, according to Allegheny County Health Department statistics provided by the task force," the Post-Gazette reports. "The Girlfriends Project was designed for Braddock, Clairton and Duquesne "because we knew nobody was doing outreach there," project coordinator, Lisa Dukes, said. As part of the project, Dukes hosts Tupperware party-style gatherings in homes of residents where she provides HIV testing and education, sexual health information, safe sex products and cash gift cards. The project is an outgrowth of the CDC"s prevention program Sisters Informing Sisters About Topics on AIDS, or SISTA, and has been so successful that CDC "has asked the task force to introduce it at the CDC"s 2009 National HIV Prevention Conference in Atlanta Aug. 23," the article states (Smith, 7/29).

Advocates Express Concern About Embryonic Stem Cell Research Guidelines As Comment Period Closes
Supporters of embryonic stem cell research have expressed concern about the impact on existing research efforts under the Obama administration"s draft guidelines outlining criteria for federal funding of stem cell research, the Washington Post reports. The public comment period for the guidelines ends Tuesday and has generated more than 20,000 comments addressing nearly every element of the proposal. The guidelines, which NIH issued in April, propose limiting federal funding for the research to stem cells derived from unused embryos created for fertility treatments and willingly donated by patients who have given written consent. Former President George W. Bush in August 2001 enacted restrictions limiting federal funding for the research to the 21 stem cell lines existing at the time. Although President Obama in March signed an executive order lifting Bush"s restrictions, some proponents of embryonic stem cell research have suggested that Obama"s plan could actually jeopardize many existing research efforts. The Obama administration is expected to issue its final version of the guidelines by July 7, the Post reports.After Bush restricted federal funding to the embryonic stem cell lines already in existence, many researchers turned to private donors and state governments for the financial support to create hundreds of new lines. Although supporters of the research initially were pleased that the Obama administration"s guidelines would allow federal funding for research on these new existing lines, some are now concerned that certain stipulations in the new guidelines could actually disqualify these research efforts from receiving federal funding. For example, NIH"s proposal requires that couples who wish to donate unused embryos for research sign a consent form indicating that they were fully informed of their alternatives. Although many fertility clinics provide information for couples about their other options, few clinics note these details in written consent forms, according to the Post. Therefore, existing stem cell lines derived from embryos donated by couples who did not sign the required consent forms could be ineligible under NIH"s draft proposal, the Post reports. In addition, many stem cell research supporters also expressed disappointment that only unused embryos created for fertility treatments would be eligible for federal funding.George Daley of the Harvard Stem Cell Institute said that the Obama administration"s guidelines "take 2009 standards and attempt to apply them retroactively, which isn"t really a standard that would allow most of the pre-existing lines to be acceptable for NIH funding." Lawrence Goldstein, director of the University of California-San Diego"s stem cell program, said, "It"s not that past practices were shoddy. But they don"t necessarily meet every letter of the new guidelines moving forward." Goldstein added that researchers would "have to throw everything out and start all over again" under the new proposed guidelines. Amy Comstock Rick, CEO of the Coalition for the Advancement of Medical Research, said that her group is "very concerned" about the funding prospects for existing research efforts, adding that if NIH officials do not modify the guidelines, "very little current research would be eligible" to receive federal funds. However, Raynard Kington, acting NIH director, said the agency is aware of the concerns and "will take them into consideration." He added that "it"s unambiguous that the intent of the president was to expand opportunities and research in this area," as long as such research is "scientifically worthy" and "ethically responsible" (Stein, Washington Post, 5/25).
News of the day
Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval To Proceed With Phase 3 Development Of OnaltaTM
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced that the European Medicines Agency (EMEA) has approved its Phase 3 protocol for Onalta (Yttrium-90 edotreotide). Onalta is the Company"s lead radiotherapeutic product candidate under development for the treatment of metastatic carcinoid and pancreatic neuroendocrine tumors in patients whose symptoms are not controlled by conventional therapy. The compound has shown the potential to selectively deliver lethal radiation to cancer cells. The proposed Phase 3 trial will confirm that administration of Onalta results in stabilization, regression or complete remission of the carcinoid tumor, and improves carcinoid-related symptoms when compared to a high-dose regimen of the current standard therapy for this disease, Sandostatin®. With EMEA"s approval of its proposed Phase 3 protocol in hand, Molecular Insight can proceed with the final clinical trial that will position Onalta for marketing authorization in the EU.
Medical Devices

Washington State Nurse-Midwife Receives The Hattie Award, American College Of Nurse-Midwives' Highest Honor

Katherine Camacho Carr, CNM, PhD, a certified nurse-midwife, professor and assistant dean of graduate studies at the Seattle University College of Nursing, is the recipient of the 2009 Hattie Hemschemeyer Award from the American College of Nurse-Midwives (ACNM.) The "Hattie" is ACNM"s most prestigious award and was presented to Carr at ACNM"s 54th Annual Meeting in Seattle. Carr has been a resident of the Seattle area for 32 years. "Kathy Carr embodies the very spirit of midwifery," said ACNM President Melissa Avery, PhD, CNM, FACNM, FAAN. For more than 30 years, she has persistently contributed to improving women and newborns" health care in the United States and abroad. Her academic works have helped shape policy and practice, including the advancement of midwifery education through offò€campus/distance learning opportunities. Her colleagues say that she is a leader in midwifery education, scholarship and clinical practice who is devoted to future midwives" success as well." A 1974 graduate of the University of Illinois, Carr has practiced midwifery in birth centers, hospitals, and homes for more than three decades. She has also taught at numerous universities, including the Frontier School of Midwifery & Family Nursing, Communityò€Based Nurseò€midwifery Program, the State University of New York (SUNY) Downstate, Philadelphia University and the Seattle Midwifery School. In addition, Carr was selected as a US Public Health Service Primary Health Care Policy Fellow in 1996; also, she received the National Perinatal Association"s National/International Award for Outstanding Contribution to Maternal Child Health in 2006. In the past, she has served as an ACNM president, vice president and regional representative. The Hattie Hemschemeyer Award, named in honor of ACNM"s first president and a pioneer of the profession, is given annually to an ACNM member who has been certified for at least ten years, has not previously been selected for the award, and has fulfilled one of the following categories: continuous outstanding contributions or distinguished service to midwifery and/or maternal child health; or, has made contributions of historical significance to the development and advancement of midwifery, ACNM, or maternalò€child health. American College of Nurse-Midwives


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):